$22 Billion By 2022? What SMPP Needs You to Know About the CBD Craze

New Buy Alert! SMPP Leading Charge To $20 Billion Cannabis Explosion! Alert: Today's new buy alert is SMPP SMPP has experienced a remarkable 2019 thus far, and could be positioned for another breakout higher. It is difficult to have the advantage in an industry where sales are predicted to be over $20 Billion in just a few years time, but one such cannabis company is likely to have a very promising future. SMPP is a "vertically integrated CBD company" with "one of the widest selections of efficacious full spectrum CBD products for various end users in the US." Unlike most companies that are focusing solely on direct to consumer, SMPP's "mission" is to be in "control" of "all facets of the supply chain." This could be a potentially massive competitive advantage over other companies in the sector as it could give SMPP the ability to "best maximize profits, control quality and manage...growth without needing or relying upon outside factors." Growth of "consumer spending on legal cannabis" is expected to "accelerate in 2019, jumping 38% to $16.9 billion" and this number is expected "to reach $31.3 billion in 2022." Most recently, "Illinois became the first state to pass a bill legalizing marijuana sales through the legislature." Last week, it was reported that "Top Congressional Republican Notes 'A Lot Of Bipartisanship' On Marijuana Banking Bill" and "Senate Hearing On Marijuana Banking Bill Could Happen This Month." A Senate hearing on cannabis business banking access would represent another significant victory for the cannabis reform movement that could further accelerate growth. Not only that, but "CBD for medical use is legal in 46 states" and "CBD derived from hemp rather than marijuana is legal in all states" according to Fortune Magazine. As reported by Fortune, a study found that "CBD Market Could Reach $16 Billion by 2025" and another study estimates that "hemp-CBD market alone could hit $22 billion by 2022." Furthermore, SMPP's "mission is to deliver clinically studied full spectrum CBD in a variety of delivery systems to an emerging market of consumers in pain conditions ranging from joint and arthritis to more acute pains stemming from all kinds of diseases and surgeries," presenting it with a potentially large market opportunity. In addition, most recently the company announced: "Strategic Management Opportunity Corporation Finalizes Acquisition of US Canniceuticals, LLC "Strategic Management Opportunity Corporation CBD Inventory Procurement" SMPP could be one of the most overlooked opportunities in this sector and could be positioned for a breakout higher. With their explosive sales campaign, their initial harvest combined with current inventory could yield $2.4 million in CBD sales from one single field this season. Get the FULL DETAILS HERE! You can do your own research and add SMPP to your trading screen today! We make no promises, but this could be the next big 100%+ you're looking for. Happy Trading! Inside Wall Street This is a PAID ADVERTISEMENT provided to customers of Schaeffer's Investment Research. Although we have sent you this email, Schaeffer's not specifically endorse this product nor is it responsible for the content of this advertisement. Furthermore, we make no guarantee or warranty about what is advertised above. Your privacy is very important to us, if you wish to be excluded from future notices, do not reply to this message. Instead, please click here. DISCLAIMER: In accordance with Section 17(b) of the Securities Act of 1933, you are hereby advised that Schaeffer’s Investment Research, Inc. "Schaeffer’s" is receiving a fee of over $1000.00 in cash, from an independent third party as compensation for the distribution of this advertisement. Schaeffer’s has not determined if the statements and opinions of the advertiser are accurate, correct or truthful. The purpose of this advertisement, like any advertising, is to provide publicity for the advertising company, its products or services. You should not rely on the information presented; you should do independent research to form your own opinion and decision. Information contained in our disseminated emails does not constitute investment, legal or tax advice upon which you should rely. The purchase of high-risk securities may result in the loss of your entire investment. Advertisements received by you are not a solicitation or recommendation to buy securities of the advertised company. An offer to buy or sell securities can be made only by a disclosure document that complies with applicable securities laws and only in the States or other jurisdictions in which the security is eligible for sale. Advertisements distributed through disseminated emails are not disclosure documents. If you are considering purchasing any securities of an advertised company, you should call your State Securities Administrator to determine if the security may be sold in your State. Many companies have information filed with State securities regulators who may be able to supply you with additional information. You also should read and review, if and to the extent available, any information concerning an advertised company available at the web sites of the U.S. Securities and Exchange Commission (the "SEC") at http://‌www.‌sec.‌gov and the Financial Industry Regulatory Authority (the "FINRA") at http://‌www.‌FINRA.‌org. We also strongly recommend that you read the SEC advisory to investors concerning Internet Stock Fraud at http://‌www.‌sec.‌gov/‌consumer/‌cyberfr.‌htm, as well as related information published by the NASD on how to invest carefully. You are responsible for verifying all claims and conducting your own due diligence. You agree and acknowledge that any hyperlinks to the website of (1) an advertised company, (2) the party issuing or preparing the information for the advertised company, or (3) other information contained in our disseminated emails is provided only for your reference and convenience. We are not responsible for the accuracy or reliability of these external sites, nor are we responsible for the content, advertising, opinions, products or other materials on external sites or information sources. If you use, act upon or make decisions in reliance on information contained in any disseminated email or any hyperlink, you do so at your own risk and agree to hold us, our officers, directors, shareholders, affiliates and agents harmless. You acknowledge that you are not relying on us, and we are not liable for, any actions taken by you based on any information contained in any disseminated email or hyperlink. You also acknowledge that we are not an investment advisory service, a broker-dealer or an investment adviser. You acknowledge that you will consult with your own advisers regarding any decisions as to any advertised company. Schaeffer's Investment Research 5151 Pfeiffer Road, Suite 250 Cincinnati, Ohio 45242